Jupiter Neurosciences, Inc. (JUNS)
$3.36+10.53%Close
SELLRECOVERY · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $122M
- Beta
- 1.88
- P/E (TTM)
- -0.17
- Short % float
- 0.21%
- Days to cover
- 1.0
- SI change
- -32.5%
- 1W
- +17.48%
- 1M
- -1.47%
- vs SPY 1W
- +17.62%
- vs SPY 1M
- -3.97%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on JUNS?
- LOPJLB’s latest quantitative signal on Jupiter Neurosciences, Inc. (JUNS) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is JUNS in?
- Jupiter Neurosciences, Inc. (JUNS) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Jupiter Neurosciences, Inc. (JUNS) do?
- Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damage…